Clostridioides Difficile Infection Recurrence Clinical Trials
3 recruiting trials for Clostridioides Difficile Infection Recurrence. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT07250724
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "Contacts and Locations". The goal of this study is to map...
Sponsor: Bactolife A/SEnrolling: 601 location
RECRUITINGPhase 2 / Phase 3NCT06979609
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Re-exposure to systemic antibiotics (i.e., antibiotics absorbed into the bloodstream) is common after a Clostridioides difficile infection (CDI) and is the strongest risk factor...
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 3001 location
RECRUITINGPhase 3NCT06237452
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive...
Sponsor: Vedanta Biosciences, Inc.Enrolling: 85220 locations